Yüklüyor......
Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials
AIM/BACKGROUND: After the introduction of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC), different studies tried to evaluate whether other systemic therapies can improve survival. To provide a comprehensive indirect treatment comparison of efficacy and safety of novel drugs,...
Kaydedildi:
| Yayımlandı: | Liver Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5704710/ https://ncbi.nlm.nih.gov/pubmed/29234637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481314 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|